Please login to the form below
Smart Thinking blog
Insights and expert advice on the key issues facing today’s pharma marketer
The most annoying ‘F’ word in healthcare
29 Jul 2019
Why fail first policies are an ugly metaphor for larger issues
Critical factors to fast-track digital health technology adoption12 Jun 2019
Stream on08 May 2019
The Netflix model and why it (kind of) works in healthcare
Cultivating a learner-led culture: agile learning and the growth mindset 07 May 2019
Organisations that follow traditional models of learning and development will falter
-
Great Expectations
30 Apr 2019
The three things to think about in expected utility theory*
-
Hidden health system costs: false positives and negatives
25 Mar 2019
Decision theory sheds light on the things we don’t often pay attention to in healthcare
-
Storm Chasers
01 Mar 2019
The way people respond to tornado warnings may have public health implications
-
Credit Score
25 Jan 2019
Asking patients to prove they can pay for healthcare is inhumane. Period.
Beneluxa: the future of European market access?12 Dec 2018
Andrew McConaghie talks to Beneluxa’s Marcel van Raaij and Biogen’s Erik Smet about their groundbreaking deal on Spinraza and what it means for European market access
Better together when buying medicines? Taking stock of the BeNeLuxA initiative11 Dec 2018
‘With Ireland being the latest to join in June 2018, there is clearly interest in the initiative that goes beyond the founding countries’
Featured jobs
-
Events Executive
-
DOE
- Client Services Director- Flexible Working
-
Negotiable
-
Senior Medical Writer
-
Competitive salary plus benefits
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Manager – Healthcare advertising
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Half of European cancer drug trials ‘biased’, says BMJ
PMHub
Fishawack Group of Companies
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
